The first shipments of an experimental antibody therapy for COVID-19 have arrived in Texas. It’s not easy to pronounce, but bamlanivimab has been shown to prevent high-risk patients from ending up in the hospital.
Newsroom
The first shipments of an experimental antibody therapy for COVID-19 have arrived in Texas. It’s not easy to pronounce, but bamlanivimab has been shown to prevent high-risk patients from ending up in the hospital.